551 related articles for article (PubMed ID: 31313064)
1. Beneficial Effects of Fingolimod in Alzheimer's Disease: Molecular Mechanisms and Therapeutic Potential.
Angelopoulou E; Piperi C
Neuromolecular Med; 2019 Sep; 21(3):227-238. PubMed ID: 31313064
[TBL] [Abstract][Full Text] [Related]
2. Modulatory Effects of Fingolimod (FTY720) on the Expression of Sphingolipid Metabolism-Related Genes in an Animal Model of Alzheimer's Disease.
Jęśko H; Wencel PL; Lukiw WJ; Strosznajder RP
Mol Neurobiol; 2019 Jan; 56(1):174-185. PubMed ID: 29687345
[TBL] [Abstract][Full Text] [Related]
3. Sphingosine 1-Phosphate Receptors in Cerebral Ischemia.
Gaire BP; Choi JW
Neuromolecular Med; 2021 Mar; 23(1):211-223. PubMed ID: 32914259
[TBL] [Abstract][Full Text] [Related]
4. Dual dose-dependent effects of fingolimod in a mouse model of Alzheimer's disease.
Carreras I; Aytan N; Choi JK; Tognoni CM; Kowall NW; Jenkins BG; Dedeoglu A
Sci Rep; 2019 Jul; 9(1):10972. PubMed ID: 31358793
[TBL] [Abstract][Full Text] [Related]
5. Preclinical and Clinical Evidence for the Involvement of Sphingosine 1-Phosphate Signaling in the Pathophysiology of Vascular Cognitive Impairment.
Chua XY; Ho LTY; Xiang P; Chew WS; Lam BWS; Chen CP; Ong WY; Lai MKP; Herr DR
Neuromolecular Med; 2021 Mar; 23(1):47-67. PubMed ID: 33180310
[TBL] [Abstract][Full Text] [Related]
6. Dysregulation of sphingosine-1-phosphate (S1P) and S1P receptor 1 signaling in the 5xFAD mouse model of Alzheimer's disease.
Jung Y; Lopez-Benitez J; Tognoni CM; Carreras I; Dedeoglu A
Brain Res; 2023 Jan; 1799():148171. PubMed ID: 36410428
[TBL] [Abstract][Full Text] [Related]
7. The Sphingosine 1-Phosphate Signaling Pathway in Epilepsy: A Possible Role for the Immunomodulator Drug Fingolimod in Epilepsy Treatment.
Leo A; Citraro R; Marra R; Palma E; Paola EDD; Constanti A; De Sarro G; Russo E
CNS Neurol Disord Drug Targets; 2017; 16(3):311-325. PubMed ID: 27823573
[TBL] [Abstract][Full Text] [Related]
8. FTY720 decreases ceramides levels in the brain and prevents memory impairments in a mouse model of familial Alzheimer's disease expressing APOE4.
Crivelli SM; Luo Q; Kruining DV; Giovagnoni C; Mané-Damas M; den Hoedt S; Berkes D; De Vries HE; Mulder MT; Walter J; Waelkens E; Derua R; Swinnen JV; Dehairs J; Wijnands EPM; Bieberich E; Losen M; Martinez-Martinez P
Biomed Pharmacother; 2022 Aug; 152():113240. PubMed ID: 35689862
[TBL] [Abstract][Full Text] [Related]
9. Loss of the neuroprotective factor Sphingosine 1-phosphate early in Alzheimer's disease pathogenesis.
Couttas TA; Kain N; Daniels B; Lim XY; Shepherd C; Kril J; Pickford R; Li H; Garner B; Don AS
Acta Neuropathol Commun; 2014 Jan; 2():9. PubMed ID: 24456642
[TBL] [Abstract][Full Text] [Related]
10. Repurposing drugs against Alzheimer's disease: can the anti-multiple sclerosis drug fingolimod (FTY720) effectively tackle inflammation processes in AD?
Leßmann V; Kartalou GI; Endres T; Pawlitzki M; Gottmann K
J Neural Transm (Vienna); 2023 Aug; 130(8):1003-1012. PubMed ID: 37014414
[TBL] [Abstract][Full Text] [Related]
11. Functional antagonism of sphingosine-1-phosphate receptor 1 prevents cuprizone-induced demyelination.
Kim S; Bielawski J; Yang H; Kong Y; Zhou B; Li J
Glia; 2018 Mar; 66(3):654-669. PubMed ID: 29193293
[TBL] [Abstract][Full Text] [Related]
12. FTY720 Attenuates Infection-Induced Enhancement of Aβ Accumulation in APP/PS1 Mice by Modulating Astrocytic Activation.
McManus RM; Finucane OM; Wilk MM; Mills KHG; Lynch MA
J Neuroimmune Pharmacol; 2017 Dec; 12(4):670-681. PubMed ID: 28620801
[TBL] [Abstract][Full Text] [Related]
13. Fingolimod Limits Acute Aβ Neurotoxicity and Promotes Synaptic Versus Extrasynaptic NMDA Receptor Functionality in Hippocampal Neurons.
Joshi P; Gabrielli M; Ponzoni L; Pelucchi S; Stravalaci M; Beeg M; Mazzitelli S; Braida D; Sala M; Boda E; Buffo A; Gobbi M; Gardoni F; Matteoli M; Marcello E; Verderio C
Sci Rep; 2017 Jan; 7():41734. PubMed ID: 28134307
[TBL] [Abstract][Full Text] [Related]
14. Fingolimod as a Treatment in Neurologic Disorders Beyond Multiple Sclerosis.
Bascuñana P; Möhle L; Brackhan M; Pahnke J
Drugs R D; 2020 Sep; 20(3):197-207. PubMed ID: 32696271
[TBL] [Abstract][Full Text] [Related]
15. The immune modulator FTY720 targets sphingosine-kinase-dependent migration of human monocytes in response to amyloid beta-protein and its precursor.
Kaneider NC; Lindner J; Feistritzer C; Sturn DH; Mosheimer BA; Djanani AM; Wiedermann CJ
FASEB J; 2004 Aug; 18(11):1309-11. PubMed ID: 15208267
[TBL] [Abstract][Full Text] [Related]
16. Neuropep-1 ameliorates learning and memory deficits in an Alzheimer's disease mouse model, increases brain-derived neurotrophic factor expression in the brain, and causes reduction of amyloid beta plaques.
Shin MK; Kim HG; Baek SH; Jung WR; Park DI; Park JS; Jo DG; Kim KL
Neurobiol Aging; 2014 May; 35(5):990-1001. PubMed ID: 24268884
[TBL] [Abstract][Full Text] [Related]
17. Sphingosine 1-phosphate but not Fingolimod protects neurons against excitotoxic cell death by inducing neurotrophic gene expression in astrocytes.
Tran C; Heng B; Teo JD; Humphrey SJ; Qi Y; Couttas TA; Stefen H; Brettle M; Fath T; Guillemin GJ; Don AS
J Neurochem; 2020 Apr; 153(2):173-188. PubMed ID: 31742704
[TBL] [Abstract][Full Text] [Related]
18. A novel BACE inhibitor NB-360 shows a superior pharmacological profile and robust reduction of amyloid-β and neuroinflammation in APP transgenic mice.
Neumann U; Rueeger H; Machauer R; Veenstra SJ; Lueoend RM; Tintelnot-Blomley M; Laue G; Beltz K; Vogg B; Schmid P; Frieauff W; Shimshek DR; Staufenbiel M; Jacobson LH
Mol Neurodegener; 2015 Sep; 10():44. PubMed ID: 26336937
[TBL] [Abstract][Full Text] [Related]
19. Mechanism of action of s1p receptor modulators in multiple sclerosis: The double requirement.
Bordet R; Camu W; De Seze J; Laplaud DA; Ouallet JC; Thouvenot E
Rev Neurol (Paris); 2020; 176(1-2):100-112. PubMed ID: 31757428
[TBL] [Abstract][Full Text] [Related]
20. Fingolimod Affects Transcription of Genes Encoding Enzymes of Ceramide Metabolism in Animal Model of Alzheimer's Disease.
Jęśko H; Wencel PL; Wójtowicz S; Strosznajder J; Lukiw WJ; Strosznajder RP
Mol Neurobiol; 2020 Jun; 57(6):2799-2811. PubMed ID: 32356173
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
